Impaired Emotional Learning and Involvement of the Corticotropin-Releasing Factor Signaling System in Patients With Irritable Bowel Syndrome
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Background & Aims Alterations in central corticotropin-releasing factor (CRF) signaling pathways have been implicated in the pathophysiology of anxiety disorders and irritable bowel syndrome (IBS). We aimed to characterize the effects of the CRF receptor 1 (CRF-R1) antagonist, GW876008, on brain and skin conductance responses (SCR) during acquisition and extinction of conditioned fear to the threat of abdominal pain in subjects with IBS and healthy individuals (controls). Methods We performed a single center, randomized, double-blind, 3-period crossover study of 11 women with IBS (35.50 ± 12.48 y old) and 15 healthy women (controls) given a single oral dose (20 or 200 mg) of the CRF-R1 antagonist or placebo. Blood-oxygen-level-dependent (BOLD) responses were analyzed using functional magnetic resonance imaging in a tertiary care setting. Results Controls had greater SCR during acquisition than extinction, validating the fear conditioning paradigm. In contrast, during extinction, the women with IBS had greater SCR than controls—an effect normalized by administration of a CRF-R1 antagonist. Although the antagonist significantly reduced activity in the thalamus in patients with IBS and controls during acquisition, the drug produced greater suppression of BOLD activity in a wide range of brain regions in IBS patients during extinction, including the medial prefrontal cortex, pons, hippocampus, and anterior insula. Conclusion Although CRF signaling via CRF-R1 is involved in fear acquisition and extinction learning related to expected abdominal pain in patients with IBS and controls, this system appears to be upregulated in patients with IBS. This upregulation might contribute to the previously reported abnormal brain responses to expected abdominal pain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965 · cited 1×
“Corticotropin-releasing factor is considered the principal coordinator of the vertebrate stress response via widespread actions on peripheral and central targets, all of which serve to orchestrate a host of autonomic, neurochemical, and behavioral responses to stress.(11,12) Perturbations to this system in humans have…”
BackgroundMacDonald, A. W., Cohen, J. D., Stenger, V. A., & Carter, C. S. (2000) · Science · doi:10.1126/science.288.5472.1835 · Cited by 3,666
The Neurocircuitry of Fear, Stress, and Anxiety Disorders
Shin, L. M., & Liberzon, I. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.83 · Cited by 2,083
Phelps, E. A., Delgado, M. R., Nearing, K. I., & LeDoux, J. E. (2004) · Neuron · doi:10.1016/j.neuron.2004.08.042 · Cited by 1,753
Neural Mechanisms of Extinction Learning and Retrieval
Quirk, G. J., & Mueller, D. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301555 · Cited by 1,645
Fear Extinction as a Model for Translational Neuroscience: Ten Years of Progress
Milad, M. R., & Quirk, G. J. (2012) · Annual Review of Psychology · doi:10.1146/annurev.psych.121208.131631 · Cited by 1,466
Rauch, S. L., Shin, L. M., & Phelps, E. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.004 · Cited by 1,397
Dunn, A. J., & Berridge, C. W. (1990) · Brain Research Reviews · doi:10.1016/0165-0173(90)90012-d · Cited by 1,352
Paulus, M. P., & Stein, M. B. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.042 · Cited by 1,325 · cited 1×
“In contrast to the generally reduced brain responses in IBS during acquisition, patients showed significantly greater activation compared with HCs in the right aINS, a brain region found to be activated in association with increased uncertainty and encoding of anticipatory signals in relation to conditioned fear.(29,3…”
ResultMilad, M. R., Wright, C. I., Orr, S. P., Pitman, R. K., Quirk, G. J., & Rauch, S. L. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.10.011 · Cited by 1,197
Sawchenko, P. E., & Swanson, L. W. (1982) · Journal of Comparative Neurology · doi:10.1002/cne.902050306 · Cited by 1,150
Heidbreder, C. A., & Groenewegen, H. J. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.09.003 · Cited by 882
Neural circuitry underlying the regulation of conditioned fear and its relation to extinction
Delgado, M. R., Nearing, K. I., LeDoux, J. E., & Phelps, E. A. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.029 · Cited by 716
Human Fear Conditioning and Extinction in Neuroimaging: A Systematic Review
Sehlmeyer, C., Schöning, S., Zwitserlood, P., Pfleiderer, B., Kircher, T., Arolt, V., & Konrad, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005865 · Cited by 543 · cited 1×
“The HIPP and aINS have also been implicated in a common core network for human aversive conditioning and are known to play a critical role in extinction learning and retrieval.(26,30) In addition, nonhuman primate studies have identified the widespread distribution of CRF and CRF-R1 throughout the PFC, HIPP, INS, and…”
BackgroundAnimal models of ‘anxiety’: Where next?
Rodgers, R. J. (1997) · Behavioural Pharmacology · doi:10.1097/00008877-199711000-00003 · Cited by 437 · cited 1×
“On the other hand, increased levels of trait and state anxiety in the IBS group might have contributed to the observed group differences in emotional learning in the current study, as described previously in patients with anxiety disorders(6,10) and rodent models of such disorders.(58,59) Our findings demonstrate the…”
ResultV. Stress and irritable bowel syndrome
Mayer, E. A., Naliboff, B. D., Chang, L., & Coutinho, S. V. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.280.4.g519 · Cited by 413
Self-citationExtending animal models of fear conditioning to humans
Delgado, M. R., Olsson, A., & Phelps, E. A. (2006) · Biological Psychology · doi:10.1016/j.biopsycho.2006.01.006 · Cited by 366 · cited 1×
“On the other hand, increased levels of trait and state anxiety in the IBS group might have contributed to the observed group differences in emotional learning in the current study, as described previously in patients with anxiety disorders(6,10) and rodent models of such disorders.(58,59) Our findings demonstrate the…”
ResultUncertainty during anticipation modulates neural responses to aversion in human insula and amygdala
Sarinopoulos, I., Grupe, D. W., Mackiewicz, K. L., Herrington, J. D., Lor, M., Steege, E. E., & Nitschke, J. B. (2010) · Cerebral Cortex · doi:10.1093/cercor/bhp155 · Cited by 241 · cited 1×
“In contrast to the generally reduced brain responses in IBS during acquisition, patients showed significantly greater activation compared with HCs in the right aINS, a brain region found to be activated in association with increased uncertainty and encoding of anticipatory signals in relation to conditioned fear.(29,3…”
ResultLackner, J. M., Lou Coad, M., Mertz, H. R., Wack, D. S., Katz, L. A., Krasner, S. S., Firth, R., Mahl, T. C., & Lockwood, A. H. (2006) · Behaviour Research and Therapy · doi:10.1016/j.brat.2005.05.002 · Cited by 120 · cited 1×
“Although this study was not designed or powered to evaluate the role of trait and state anxiety on emotional learning in IBS patients, our findings are consistent with an extensive literature on such a relationship.(55,56) On the one hand, conditioned fear to aversive signals from the body and an up-regulation of the…”
ResultLabus, J., Gupta, A., Gill, H. K., Posserud, I., Mayer, M., Raeen, H., Bolus, R., Simren, M., Naliboff, B. D., & Mayer, E. A. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12171 · Cited by 64
Self-citationIncreased Acoustic Startle Responses in IBS Patients During Abdominal and Nonabdominal Threat
Naliboff, B. D., Waters, A. M., Labus, J. S., Kilpatrick, L., Craske, M. G., Chang, L., Negoro, H., Ibrahimovic, H., Mayer, E. A., & Ornitz, E. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318186d858 · Cited by 45
Self-citationFabio, R. D., St-Denis, Y., Sabbatini, F. M., Andreotti, D., Arban, R., Bernasconi, G., Braggio, S., Blaney, F. E., Capelli, A. M., Castiglioni, E., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800744m · Cited by 34 · cited 1×
“GW876008 (GlaxoSmithKline, Research Triangle Park, NC) is a highly selective and potent antagonist for the G-protein coupled CRF-R1 subtype.(22) Based on phase II clinical trials in patients with IBS, 20-mg and 200-mg doses of GW876008 were chosen in an attempt to provide a sufficient therapeutic range.”
Background
Cited by
Mayer, E. A., Labus, J. S., Tillisch, K., Cole, S. W., & Baldi, P. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.121 · Cited by 277
Self-citationThe neurobiology of irritable bowel syndrome
Mayer, E. A., Ryu, H. J., & Bhatt, R. R. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01972-w · Cited by 257
Self-citationA Rome Working Team Report on Brain-Gut Behavior Therapies for Disorders of Gut-Brain Interaction
Keefer, L., Ballou, S. K., Drossman, D. A., Ringstrom, G., Elsenbruch, S., & Ljótsson, B. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.09.015 · Cited by 213
Labanski, A., Langhorst, J., Engler, H., & Elsenbruch, S. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104501 · Cited by 200
Placebo effects and their determinants in gastrointestinal disorders
Elsenbruch, S., & Enck, P. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.117 · Cited by 173
Metadata
- Authors
- Labus, J. S., Hubbard, C. S., Bueller, J., Ebrat, B., Tillisch, K., Chen, M., Stains, J., Dukes, G. E., Kelleher, D. L., Naliboff, B. D., Fanselow, M., & Mayer, E. A.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 145
- Issue
- 6
- Pages
- 1253-1261.e3
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2091338428
- Cited by
- 90
- References
- 23
- FWCI
- 8.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.